Amevive^® (Alefacept)

  Content:

COMPLIANCE

• Alefacept is a well tolerated drug with a very impressive safety profile.
• It has a convenient and flexible method of administration (IM)
• Patient self-administration is possible (nurse administration available)
• Patient expectations must be set appropriately:



• The onset of response occurs on average at 8 weeks; maximal response, for one course, occurring at 20 weeks (8 weeks after the last dose)
• Completing 2 courses of therapy has shown remittive effects lasting >12 months


• Clinical experience combining Alefacept with UV therapy, oral retinoids, methotrexate and cyclosporin has been well tolerated

Amevive Care Program

The program offers:

• Help in determining and acquiring reimbursement
• A personal nurse coordinator to help guide patient expectations
• In-office, self-administration or Amevive nurse administration available
• A toll-free hotline available 7 days a week (1-877-AMEVIVE or 1-877-263-8483) staffed by specially trained nurses
• An Amevive patient starter kit
• Home delivery if needed

Next:   Side Effects, Safety and Risks

    More Presentations: